Switching to Denosumab or Bisphosphonates After Completion of Teriparatide Treatment in Women With Severe Postmenopausal Osteoporosis.
Endocr Pract
; 27(9): 941-947, 2021 Sep.
Article
in En
| MEDLINE
| ID: mdl-34111556
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Osteoporosis, Postmenopausal
/
Diphosphonates
/
Bone Density Conservation Agents
/
Denosumab
Type of study:
Observational_studies
/
Prognostic_studies
Limits:
Aged
/
Female
/
Humans
Language:
En
Journal:
Endocr Pract
Journal subject:
ENDOCRINOLOGIA
Year:
2021
Document type:
Article
Country of publication:
United States